News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Could Bristol-Myers Squibb Company (BMY) be a Target of Bribery?


4/27/2012 8:02:25 AM

U.S. drugmaker Bristol-Myers Squibb Co said on Thursday that it received a subpoena from securities regulators regarding its sales and marketing practices in various foreign countries. Bristol-Myers, in a filing, said it received the subpoena from the U.S. Securities and Exchange Commission (SEC) last month in connection with an investigation under the Foreign Corrupt Practices Act (FCPA). The company said it was cooperating with the government in its investigation. It declined to divulge what countries or products were involved in the probe or to give any details beyond the brief statement in the filing.

Read at Reuters
Read at Wall Street Journal

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES